Sherlock Biosciences
Sherlock Biosciences Raises $80M in Series B Financing
The company will use the funding to develop diagnostic tests based on CRISPR and synthetic biology that can operate without complex instrumentation.
Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests
Sherlock Biosciences said that under the agreement, Rokline Health will develop and manufacture high-throughput CRISPR kits in the US.
Sherlock Bio Foundation Licenses CRISPR Tech to LogicInk
LogicInk said it will use the CRISPR technology to develop an instrument-free diagnostic biosensor for the detection of SARS-CoV-2.
Sherlock Bio Foundation Licenses CRISPR Tech to Cooper International, United PPE for COVID-19 Tests
The agreements will increase access to testing in Asia through United PPE and in the Middle East through Cooper International, the foundation said.
In Brief This Week: OpGen, Hologic, Exact Sciences, Thermo Fisher, and More
News items for the in vitro diagnostics industry for the week of Jan. 4, 2021.